OSSIO launches smaller, stronger, smarter bio-integrative suture anchors for orthopedic use

OSSIO's bio-integrative suture anchors can be used in a wide variety of procedures: ©EdwardOlive - stock.adobe.com

OSSIO Inc. has expanded its soft-tissue fixation portfolio with the launch of its OSSIOfiber 2.5mm Suture Anchors, a next-generation, bio-integrative alternative to metal implants. The new device is designed to enhance procedures such as Brostrom repair for lateral ankle instability by offering greater strength, natural healing, and easier integration with standard surgical techniques.

“With these new small OSSIOfiber Suture Anchors, I can approach a familiar procedure with the same technique I’ve always trusted, only now I’m using a smaller, stronger, smarter material that I believe is the future of orthopedics,” said Thomas Philip San Giovanni, a board-certified orthopedic surgeon with Baptist Health South Florida. “Outcomes with this novel material aren’t just equivalent, they’re better in my experience.”

The 2.5mm suture anchors provide 55% greater pull-out strength compared to leading bio-composite anchors, according to the company. OSSIO CEO Brian Verrier called it the “first small, fully bio-integrative suture anchor,” emphasizing its superior performance and low impact on patients. “With this anchor, surgeons can perform these procedures with less impact and better results for patients, while adding fixation strength,” he said.

The suture anchors can be used in a wide range of procedures across the foot, ankle, knee, shoulder, elbow, hand, and wrist. Available in both pre-loaded and unloaded configurations, the devices integrate into familiar workflows and use standard instrumentation.

Advancements in bio-integrative orthopedic technology

Orthopedic surgery is undergoing a quiet revolution as the field shifts away from metal and bio-inert implants toward more natural, integrative solutions that promote healing while minimizing long-term complications. OSSIOfiber technology is part of a growing segment of medical innovation that combines mechanical performance with biological compatibility.

These implants use a proprietary mineral fiber matrix designed to mimic the structural properties of bone while promoting natural bone regeneration and eventual full integration. Unlike metal, which can interfere with imaging or lead to stress shielding, and unlike traditional absorbable materials that may lose strength too early, OSSIOfiber implants maintain strength throughout healing and then disappear—leaving behind only healed bone.

Bio-integrative materials are especially appealing for pediatric and active adult populations, where eliminating the need for follow-up hardware removal surgeries is a major benefit. In many cases, the use of such materials also aligns well with current reimbursement systems and familiar surgical workflows, easing adoption.

Other companies in the orthopedic space are also exploring bioactive ceramics, magnesium-based alloys, and polymer composites that encourage osteogenesis while maintaining necessary fixation strength.